• OPEN AN ACCOUNT
Indian Indices
Sensex
77,654.60 888.68
( 1.16%)
Global Indices
Nasdaq
52,776.51 545.43
(1.04%)
Dow Jones
7,451.65 17.47
(0.23%)
Hang Seng
61,006.88 -1,358.04
(-2.18%)
Nikkei 225
10,879.18 97.43
(0.90%)
Forex
USD-INR
95.97 -0.70
(-0.72%)
EUR-INR
109.29 -0.89
(-0.81%)
GBP-INR
127.84 -1.20
(-0.93%)
JPY-INR
0.59 0.00
(-0.81%)

EQUITY - MARKET SCREENER

Onyx Biotec Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
93585
INE0WVU01018
30.5601085
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ONYX
0
73.98
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Consecutive Commodities standalone net profit rises 60.00% in the March 2026 quarter
May 26,2026
Net profit of Consecutive Commodities rose 60.00% to Rs 0.88 crore in the quarter ended March 2026 as against Rs 0.55 crore during the previous quarter ended March 2025. Sales rose 7.82% to Rs 16.40 crore in the quarter ended March 2026 as against Rs 15.21 crore during the previous quarter ended March 2025.

For the full year,net profit rose 21.08% to Rs 2.70 crore in the year ended March 2026 as against Rs 2.23 crore during the previous year ended March 2025. Sales rose 156.11% to Rs 57.88 crore in the year ended March 2026 as against Rs 22.60 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales16.4015.21 8 57.8822.60 156
OPM %4.94-0.66 -5.305.09 -
PBDT0.820.07 1071 3.282.32 41
PBT0.820.07 1071 3.282.32 41
NP0.880.55 60 2.702.23 21